Old Dominion University

ODU Digital Commons
Nursing Faculty Publications

Nursing

2021

Guidelines on Prescriptive Authority for Nurses 2021
David Stewart
Madrean Schober
Lisa Nissen
Elissa Ladd
Kimberley Lamarche

See next page for additional authors

Follow this and additional works at: https://digitalcommons.odu.edu/nursing_fac_pubs
Part of the Nursing Commons, Pharmacy Administration, Policy and Regulation Commons, and the
Vocational Education Commons

Original Publication Citation
Stewart, D., Schober, M., Nissen, L., Ladd, E., Lemarche, K., Bornival, M., Gray, D. C., Sevilla, S., Kroezen, M.,
& Wong, F. (2021). Guidelines on prescriptive authority for nurses 2021. International Council of Nurses.
https://www.icn.ch/system/files/2022-08/ICN_Nurse_prescribing_guidelines_EN.pdf

This Report is brought to you for free and open access by the Nursing at ODU Digital Commons. It has been
accepted for inclusion in Nursing Faculty Publications by an authorized administrator of ODU Digital Commons. For
more information, please contact digitalcommons@odu.edu.

Authors
David Stewart, Madrean Schober, Lisa Nissen, Elissa Ladd, Kimberley Lamarche, Marie-Lyne Bournival,
Deborah Gray, Sonia Sevilla, Marieke Kroezen, and Frances Wong

This report is available at ODU Digital Commons: https://digitalcommons.odu.edu/nursing_fac_pubs/60

INTERNATIONAL COUNCIL OF NURSES

GUIDELINES ON PRESCRIPTIVE
AUTHORITY FOR NURSES
2021

All rights, including translation into other languages, reserved. No part of this publication may be
reproduced in print, by photostatic means or in any other manner, or stored in a retrieval system,
or transmitted in any form, or sold without the express written permission of the International
Council of Nurses. Short excerpts (under 300 words) may be reproduced without authorisation,
on condition that the source is indicated.
Copyright © 2021 by ICN - International Council of Nurses,
3, place Jean-Marteau, 1201 Geneva, Switzerland
Copyright for all photos: International Council of Nurses
ISBN: 978-92-95099-91-3

INTERNATIONAL COUNCIL OF NURSES

GUIDELINES ON PRESCRIPTIVE
AUTHORITY FOR NURSES
2021



AUTHORS
Lead Author
David Stewart, RN, BN, MHN
Associate Director (consultant), Nursing and Health Policy
International Council of Nurses

Contributing Authors
Madrean Schober, PhD, MSN, ANP, FAANP
President, Schober Global Healthcare Consulting
International Healthcare Consultants, New York, NY, USA
Lisa Nissen, BPharm, PhD
AdvPracPharm, FPS, FHKAPh, FSHP
Head of School of Clinical Sciences,
Queensland University of Technology, Australia
Elissa Ladd, PhD, FNP-BC
Professor, School of Nursing
Director, Global Health Equity and Innovations Program, USA
Kimberley Lamarche, CD, NP, DNP
NP Program Director/Associate Professor
Athabasca University, Canada
Marie-Lyne Bournival, BSc, PG Dip (Health Sc), MN
Nurse Practitioner, New Zealand Executive Committee and the Nursing Council of New Zealand
NP Assessment Panel, New Zealand
Dr. Deborah Gray, DNP, ANP-BC, FNP-C, FAANP
Associate Graduate Program Director MSN/DNP Programs
Clinical Associate Professor
Old Dominion University School of Nursing
US Fulbright Scholar Sub-Saharan Africa
Virginia State Representative, American Association of Nurse Practitioners, USA
Sonia Sevilla, PhD
Consultant Nurse, Area of Nursing Clinical Project Hospital Clinic, Barcelona, Spain
Marieke Kroezen, PhD
Researcher, NIVEL,
Netherlands Institute for Health Services Research, Utrecht, the Netherlands
Frances Wong, Professor, RN, PhD, FAAN, FHKAN (Education & Research)
Associate Dean, Faculty of Health & Social Sciences
Professor, School of Nursing
The Hong Kong Polytechnic University
Hung Hom, Hong Kong, China SAR

3

ACKNOWLEDGEMENTS
ICN would like to thank the following people who provided a preliminary review of the guidelines:

• Fariba Al Darazi, Prior Regional Director of Nursing, WHO, Regional Office of the Eastern
Mediterranean Region, Bahrain

• Heather Henry-McGrath, President, Jamaica Association of Nurse Practitioners, International
• Ambassador-American Association of Nurse Practitioners
• Mabedi Kgositau, International Ambassador-American Association of Nurse Practitioners,
University of Botswana, Botswana

• Pilar Espinoza, Director, Postgraduate, research and international affairs at the health care
sciences faculty of the San Sebastián University, Chile

• Karen Koh, Advanced Practice Nurse, National University Hospital, Singapore Nursing Board,
Singapore

• Jaap Kappert, Policy Advisor Dutch Association Nurse Practitioners, Netherlands
• Desiree van den Hurk, Nurse Practitioner, Netherlands
• Jenny Carryer, Professor, Massey University, New Zealand
• Sylvia Cassiani, Regional Advisor for Nursing, Pan American Health Organization
• Bongi Sibanda, Lead Educator for Advanced Clinical practice, NHS, United Kingdom
• Denise Bryant-Lukosius, Professor, McMaster University, Canadian Centre for APN Research,
Canada

• Anna Suuturla, Head of International Affairs, Finnish Nurses’ Association, Finland
• Martin Duignan, Clinical Facilitator at Trinity College Dublin, Ireland
• Karen Brennan, Past President, Irish Association of Nurse Practitioners, Ireland
• Jeroen Peters, Program Director, Nimigen University, Netherland
• Michal Boyd, Nurse Practitioner/Professor, University of Auckland, New Zealand
• Vanessa Maderal, Adjunct Professor, University of the Philippines, Philippines
• Zhou Wentao, MScN Programme, National University of Singapore, Singapore
• Nelouise Geyer, CEO, Nursing Education Association, Pretoria, South Africa
• Katrina Maclaine, Associate Professor, London South Bank University, United Kingdom
• Melanie Rogers, Chair, ICN Nurse Practitioner/Advanced Practice Network, United Kingdom
• Josette Roussel, Directrice services cliniques at Hôpital Montfort, Canada
• Daniela Lehwaldt, Deputy Chair, ICN Nurse Practitioner/Advanced Practice Network,
Ireland/Germany

• Andrew Scanlon, Senior Lecturer, University of Melbourne, Australia

4

GUIDELINES ON PRESCRIPTIVE AUTHORITY FOR NURSES – 2021

TABLE OF CONTENTS
GLOSSARY OF TERMS................................................................................................................6
FOREWORD..................................................................................................................................8
PURPOSE OF THE ICN GUIDELINES ON PRESCRIPTIVE AUTHORITY FOR NURSES.........9
CHAPTER ONE: INTRODUCTION..............................................................................................10
1.1

Background...................................................................................................................10

1.2 Nurse Prescribing: What the evidence tells us..........................................................11
CHAPTER TWO: MODELS OF NURSE PRESCRIBING............................................................12
2.1

Differentiating prescribing models (Adapted from Nissen et al. 2010)...................14

2.2

What can nurses prescribe?........................................................................................15

2.3 Additional considerations............................................................................................15
2.4

Immunization.................................................................................................................17

CHAPTER THREE: THE CASE FOR ACTION...........................................................................18
3.1

Universal Health Coverage..........................................................................................18

3.2

Medication safety..........................................................................................................18

CHAPTER FOUR: ORGANISATIONAL AND TEAM SUPPORT FOR SAFE NURSE
PRESCRIBING.............................................................................................................................20
4.1

Decision support systems...........................................................................................20

4.2

Clinical governance, policies and procedures..........................................................20

4.3

Peer support and relationships with interprofessional teams.................................21

CHAPTER FIVE: A FRAMEWORK TO DEVELOP SAFE AND COMPETENT PRESCRIBING
FOR THE NURSING PROFESSION............................................................................................22
CHAPTER SIX: MOTIVATION FOR NURSES TO SEEK PRESCRIPTIVE AUTHORITY...........28
CHAPTER SEVEN: CRITICAL ELEMENTS SUPPORTING THE DEVELOPMENT
AND ENHANCEMENT OF NURSE PRESCRIBING ..................................................................29
7.1 Clinical guidelines: A professional standard.............................................................29
CHAPTER EIGHT: C
 ONCLUSION..............................................................................................30
ICN POSITION ON PRESCRIPTIVE AUTHORITY FOR NURSES..............30
APPENDICES..............................................................................................................................31
Appendix 1: Differentiating between dependent/supplementary
and independent prescribing ..............................................................................................31
Appendix 2: Nurse prescribing: The global regulatory landscape – 2020.......................32
Appendix 3: WHO Strategic Framework of the Global Patient Safety Challenge...........39
REFERENCES.............................................................................................................................40

5

GUIDELINES ON PRESCRIPTIVE AUTHORITY FOR NURSES – 2021

GLOSSARY OF TERMS
Competence

Competence describes a state of capability of a person to perform activities and tasks to a predefined standard. This incorporates having the requisite competencies to do this. Competence is
what a healthcare worker can do, whereas performance is what a health worker does do. There
are many contributing factors to a health worker’s performance at a given time or in a given
setting. Some of these are associated with personal factors such as life-events. Others are contextual such as support, supervision, workload, and ready access to resources. Competence is
therefore multi-dimensional and dynamic. It changes with time, experience and setting (Gebbie
2008).
Competencies

Competencies are actions that are observable in the execution of one’s practice. In other words,
competencies are applied skills and knowledge that enable people to perform work (Gebbie 2008).
Credentialing

“Credentialing is a term applied to processes used to designate that an individual, programme,
institution or product has met established standards set by an agent (governmental or non-
governmental) recognized as qualified to carry out this task. The standards may be minimal and
mandatory or above the minimum and voluntary. Licensure, registration, accreditation, approval,
certification, recognition or endorsement may be used to describe different credentialing processes, but this terminology is not applied consistently across different settings and countries.
Credentials are marks or “stamps” of quality and achievement communicating to employers,
payers, and consumers what to expect from a “credentialed” nurse, specialist, course or programme of study, an institution of higher education, hospital or health service, or healthcare product, technology, or device. Credentials may be periodically renewed as a means of assuring
continued quality and they may be withdrawn when standards of competence or behaviour are
no longer met.” (ICN 2006).
Pharmaceutical (Medicine, Drug)

A pharmaceutical is any substance or pharmaceutical product for human or veterinary use that
is intended to modify or explore physiological systems or pathological states for the benefit of
the recipient. In these guidelines, the terms drug, medicine, and pharmaceutical are used interchangeably (WHO 2009).
Prescribing

An evolving process involving the steps of information gathering, clinical decision-making, communication and evaluation which results in the initiation, continuation or cessation of a medication
(Adapted from NPS MedicineWise 2021). Prescribing is a complex process that requires in-depth
understanding of clinical pharmacology and disease, clinical judgement to weigh the risks and
benefits of a treatment and attention to detail, all within an unpredictable environment (Abuzour,
Lewis & Tully 2018). Prescribing is clearly differentiated from the supply of medication or its
administration to patients.
Prescription

A prescription is the direction or instruction from a qualified healthcare professional to issue and
administer a medicine or treatment or care to their patients (WHO 2009). Although a prescription may sometimes initially be issued as a verbal order, in order to comply with legislative and
regulatory requirements, this will typically be followed with a written instruction that bears the
6
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prescriber’s signature (this may be in handwritten or electronic format). The term ‘prescription’
has a legal implication and implies that a prescriber takes responsibility for the clinical care of that
patient. In these guidelines, the term prescription will refer to the written order for a medicine or
therapeutic (whether handwritten or electronic) with the understanding that this may sometimes
manifest as a verbal order in the first instance (Nissen, Lynne & Bettenay 2015).
Prescriptive authority

The term prescriptive authority refers to the level or extent to which a healthcare professional may
legally prescribe. Depending on the provisions within the legislation under which the professional
is practicing, their prescriptive authority may be broad or limited (Nissen, Lynne & Bettenay 2015).
Scope of Practice

“The scope of practice is not limited to specific tasks, functions or responsibilities but includes
direct care giving and evaluation of its impact, advocating for patients and for health, super
vising and delegating to others, leading, managing, teaching, undertaking research and developing health policy for health care systems. Furthermore, as the scope of practice is dynamic and
responsive to health needs, development of knowledge, and technological advances, periodic
review is required to ensure that it continues to be consistent with current health needs and supports improved health outcomes” (ICN 2013).
Standards

“Standards are authoritative statements by which the nursing profession describes the responsibilities for which its practitioners are accountable. Standards reflect the values and priorities of
the profession and provide direction for professional nursing practice and a framework for the
evaluation of this practice. They also define the nursing profession’s accountability to the public
and the outcomes for which nurses are responsible” (American Nurses Association 2010).

7
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FOREWORD
Nurse prescribing has existed for over 50 years in some regions of the world. The diverse global
nurse prescriptive authority landscape will be highlighted in this important publication. A framework embedding core components for safe and competent prescribers necessitates appropriate
education, aligned regulatory authority and continuing professional development to uphold competencies. Evidence-informed models of nurse prescribing will weave in organisational and team
support considerations required.
Nurse prescribing guidance is intended to support nurses, teams, associations, organisations,
educators, regulators and governments worldwide. Nations and regions can assess their population needs, while balancing nurses’ capacity. Motivation for planning, implementing, sustaining
and monitoring targeted outcomes require thoughtful strategy.
Healthcare workforce policies supporting nurses working to their level of education and skills
improve job satisfaction and may advance nursing recruitment and retention strategies. However,
respecting the professional nurses experience, knowledge, skill, judgement, decision making,
autonomy, accountability and choice is paramount. Both the professional and individual nurses’
scope of practice must be appreciated and respected.
Nurse prescribing model competencies can be adapted to country needs, respond to people
centredness from the lens of culturally sensitive communities, to enhance access to appropriate
mediations and quality health services. Nurses can respond to the Global Patient Safety challenge
by focusing on key action areas, including patient engagement, polypharmacy and transitions in
care.
As Chief Nurse and a Nurse Practitioner who prescribes, I appreciate the significant system
impacts that nurse prescribing offers to improve timely access to quality care across the lifespan.
Nurse prescribing targets preventative health, reduces illness and disease, while also responding
to public health emergencies. Nurses embed experience, knowledge, critical inquiry, care planning and prescribing evidence tailored to improving health, while also leveraging their leadership
and clinical service delivery capacity.
The WHO Global Strategic Directions for Nursing and Midwifery 2021–2025 policy priorities are
advanced through nurse prescribing. Nurse prescribing roles target the practice policy pillars
through education, leadership and service delivery supporting improved population health outcomes across diverse practice settings.
ICN prescribes a global call to action for national and regional assessments to leverage nurse
prescribing as a possible measure to enhance access to care continuity, universal health coverage and patient safety and to close the immunization and primary care gaps, experienced inter
nationally from the COVID effect. Nurse prescribing requires affirming enabling commitments,
while supporting expediting the removal of barriers for maximal success.
Michelle Acorn,
ICN Chief Nurse
DNP, NP PHC/Adult, CGNC, FCAN
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PURPOSE OF THE ICN GUIDELINES
ON PRESCRIPTIVE AUTHORITY
FOR NURSES
The purpose of these guidelines is to facilitate a common understanding of nurse prescribing
to inform policymakers, educators, regulators, healthcare planners, nurses, and other healthcare professionals. The paper recognises the diversity that currently defines nurse prescribing by
describing current practice and nurse prescribing models globally. The emphasis in this guidance
paper is on common principles and best practice as prescriptive authority for nurses becomes
an increasingly important component of their scope of practice and role contributions to support
health.
Worldwide, nursing practice has become more complex with nurses developing innovative
extended roles and levels of practice. Prescriptive authority is one feature of this advancement in
nursing practice. The drivers for nurse prescribing are sensitive to the country context and need.
As a result, the approach to defining and implementing nurse prescribing differs by country or
region. The differences between countries reflect differences in healthcare systems, the maturity
of nursing within the system and governmental authority that has influence over decision making
and policy.
Prescriptive authority for nurses is an ongoing process. Approaches to implementation and development of nurse prescribing require strong leadership and proactive action to promote this essential service for healthcare provision internationally.

9
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CHAPTER ONE

INTRODUCTION
Prescriptive authority for nurses and allied health professionals has been gaining momentum in
many countries across the world. Much of this drive has come as a response to the changing
landscape of healthcare demands and concerns regarding access to care, the evolution of healthcare systems and the professionals who provide care. It is important to note that the roles and
responsibilities of all healthcare professionals evolve in response to the demands and needs of
individuals and communities. Prescriptive authority has been a positive and effective example of
this type of change.
A range of healthcare professionals (e.g. nurses, midwives, optometrists, podiatrists, dieticians,
pharmacists, paramedics, physiotherapists, radiographers, others) have prescriptive authority.1
These professions, their education and professional development, credentialing and models of
prescribing often differ within and between countries. Although there is limited standardisation, the
specific aims of prescriptive authorisation for healthcare professionals to prescribe are generally
related to:

• enhancing patient access to treatment
• improving patient outcomes without compromising patient safety
• utilising the optimal potential of the skills and expertise of health professionals in order
to provide complete episodes of care (Cope, Abuzour & Tully 2016; Maier 2019)

• supportive legal protection for the prescriber and others with delegated responsibilities.
With these aims in mind, there is a need to provide guidance on nurse prescribing to protect the
public, promote healthcare services and support the nursing profession as it matures in this area.
ICN guidelines aim to promote a level of consistency and support countries in developing a framework for clinical practice as it relates to prescriptive authority for nurses.

1.1

Background

The role and function of nurses is evolving
and changing worldwide. Nursing practice
has become more complex and diverse as
nurses are an increasingly visible and pivotal
part of multidisciplinary teams with their own
body of knowledge and expertise in managing
patient care. Nurses are developing up-to-date
advances in the provision of healthcare services; prescriptive authority is one aspect of
these advances in the nursing profession.

prescribing follows a distinctive pattern in different countries. This issue extends beyond
nursing to collaboration and alliances with other
healthcare professionals as well as with representatives from governmental agencies and
consumer advocate groups.
This guidance paper examines the trends and
issues relevant to introducing, implementing
and supporting nurse prescribing. The paper
draws on a review of systematic literature
reviews, unpublished grey literature, internet
searches and consultation with key informants
on nurse prescribing.

The incentive for nurse prescribing is sensitive
to the country context and the healthcare culture
in which this possibility develops. Therefore, the
approach to defining and implementing nurse

-1

Although these professions may have prescriptive authority, their privileges are not identical.
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1.2 Nurse Prescribing: What the evidence tells us
Prescribing has been part of nursing practice
for certain nurses in some countries for several decades. The level of education and credentialing for nurse prescribing varies across
jurisdictions and ranges from diploma prepared
generalist nurses to advanced practice nurses
with master’s or doctoral degrees. There are
different and varying models of prescriptive
authority for nurses. These will be further

elaborated in the following sections of these
guidelines.
The following section provides an analysis of
available syntheses based on a review of the
literature. It was conducted to describe and
define patterns of prescriptive authority for
nurses.

Summary of the literature review

provided. Additionally, there must be
consistency in definition for each of the
prescribing practices (Cooper et al. 2008;
HealthWorkforceAustralia 2013; Kroezen
et al. 2011a; Weeks et al. 2016a).

1. Nurses practising with varying but high
levels of prescribing autonomy, in a range
of settings, are able to prescribe safely and
are as effective as other prescribers (Clark
et al. 2011; Latter & Courtenay 2004;
Weeks et al. 2016b).

5. The variability in preparation for nurse
prescribing practice is concerning
as is the lack of clarity surrounding
a differentiation between requirements
for independent and supplemental
prescribing. Most studies examining nurse
prescribing occurred in countries where
the ability to prescribe is at the general
level of registration. This suggests that
nurse prescribing occurs most often at
the post-basic level and that it is at this
level where improvements in education
are needed (Kroezen et al. 2011a:
Mboweni & Makhado 2019; McIntosh
et al. 2016).

2. The inability of nurses to prescribe
results in the delivery of fragmented care
and negatively impacted on the overall
quality of healthcare (Casey et al. 2020;
Creedon et al. 2015; Mathibe, Hendricks
& Bergh 2015).
3. Prescriptive authority for nurses can
improve effective and efficient healthcare
service provision and facilitate the
provision of more integrated patient care,
increased professional satisfaction and
improve the overall quality of the health
service (Hanrahan & Williams 2017;
Office of the Nursing & Midwifery Service
Director 2020; Park, Han & Pittman 2020;
Phillips 2020; Watson 2020).

6. Many jurisdictions have a requirement
for a set period of clinical experience prior
to initiating prescribing practice. A strong
clinical background and solid clinical
knowledge are foundational to effective
prescribing practice, regardless of level
of nurse (Abuzour, Lewis & Tully 2018;
McIntosh et al. 2016).

4. The practice of prescribing by nurses
falls within three distinct categories:
independent prescribing, supplementary
prescribing and prescribing via a structured
prescribing arrangement (or protocol).
The adjustment of previously prescribed
medications or treatments within a
pre‑determined range was not considered
prescribing within one of these three
categories. Jurisdictions must be clear
about the category of prescribing under
consideration for appropriate education
and support for the practice to be

7. Nurse prescribing is progressively
becoming an important role within nursing
practice and improves job satisfaction
and self-empowerment (Casey et al. 2011;
Ling et al. 2017; Mabelane et al. 2016;
Nutall 2018).

11
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CHAPTER TWO

MODELS OF NURSE PRESCRIBING
Internationally there has been a steady increase in the number of healthcare professionals outside
of the medical profession that have prescriptive authority. Examples of these professionals include
nurses, midwives, paramedics, optometrists, pharmacists, dentists, physiotherapists, podiatrists
and radiographers. The supportive development of these professions to prescribe has improved
access to quality safe and affordable healthcare services.
The origin of regulated nurse prescribing began in the United States of America (USA) in the
1970s and now extends to countries in all World Health Organizations (WHO) regions (Weeks
et al. 2016a). Whilst the models of prescriptive authority differ worldwide, there are a number
of core components that allow for the summation of these elements into the following broad
categories.

1. Independent prescribing
Legally permitted and qualified independent
prescribers are responsible for the clinical
assessment of a patient, the establishment of
a diagnosis and decisions about the appropriateness of a medication, treatment or appliance, including the issuing of a prescription.

Based on the country context, prescribing can
take place from a limited or open formulary.
Independent prescribing is also called initial,
autonomous, substitutive and open prescribing
(Abuzour, Lewis & Tully 2018; Kroezen et al.
2011a).

2. Supplementary prescribing (Dependent2)
A voluntary partnership between an independent prescriber and a supplementary prescriber. The independent prescriber carries
out the initial assessment and diagnosis; the
supplementary prescriber prescribes from an
open or limited formulary and consults with

the independent prescriber before issuing
the prescription. Supplementary prescribing
is also called dependent, collaborative, semi-
autonomous or complementary prescribing
(Abuzour, Lewis & Tully 2018; Kroezen et al.
2011a; Latter & Courtenay 2004).

3. Prescribing via a structured prescribing arrangement (Protocol)
Designed for a specific group of patients who
have a particular condition; medications are only
provided within the terms of a pre-determined
protocol. Prescribing via a structured prescribing arrangement is not considered independent
prescribing but may be considered a form of
supplementary prescribing (Abuzour, Lewis &
Tully et al., 2018; Kroezen et al., 2011a; Gielen
et al. 2014). Based on Patient Group Directive
(PGD) to be a separate type of prescribing,

there are sufficient commonalities between the
use of a protocol-driven approach and supplementary prescribing that it can be considered
to be a subgroup within that category. Latter
and Courtenay (2004), for example, define
supplementary prescribing to be prescribing
according to a clinical management plan that
has been approved by an independent prescriber and references protocols as necessary
for this practice.

-2

Even if the model is dependent, the prescriber is still independently responsible and accountable for the decisions that they make within the prescribing
model and relationship.

12

CHAPTER TWO: MODELS OF NURSE PRESCRIBING

4. Prescribing to administer
Healthcare professionals may have delegated
authority under a pre-approved protocol and
conditions for immediate medication administration (Crown 1999). This is often used as part
of emergency response to an immediate health
problem causing potential harm to the patient
(Nissen et al. 2010). This model is most frequently used in emergency situations, e.g. the

use of medicines on emergency carts/crash
trolleys for life threatening conditions including
cardiac arrest, anaphylaxis, respiratory distress and other. This model is often used by
first responders to make an emergent decision under a clinical protocol where they then
administer a medicine. The second most used
model is by nurses in vaccination programmes.

5. Time and Dose prescribing
In this description, healthcare professionals
are only allowed to alter the time and/or the
dosage of a particular medication. Although
referred to as prescribing in some contexts, in

this guidance paper, time and dose administration by nurses is not considered prescribing
(Kroezen et al. 2011b).

Supplementary information
• As described above, nurse prescribing

• In considering these models, it is important

is a broad term used to describe a variety
of models. Whilst each of these models
has a good evidence base, it is important
that countries clearly understand and
delineate these models as they relate
to the practice in their country.

to note that they are not hierarchical.
Instead, they reflect the level of ‘decision
making’ and ‘accountability’ that the nurse
prescriber has (Nissen et al. 2010).

• The models may need adapting to meet

country specific contexts and may evolve
over time.

• Professional boundaries and acceptance

of the models are often highly debated
during the initiation and implementation
phase of nurse prescribing. It is important
that there is consistent use of terminology
to reduce confusion and increase clarity.

13
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Prescribing
restrictions

PRESCRIBE
TO ADMINISTER

PROTOCOL

SUPPLEMENTARY/DEPENDENT

INDEPENDENT

Prescribe for immediate
administration only

Prescribe by protocol or limited
formulary

Prescribe following referral from or collaborative agreement
with an independent prescriber

Independently diagnose condition
(rather than symptoms)

Very limited formulary
of emergency medicines
or agreed list

Prescribe after a diagnosis is made.
A protocol prescriber has the capacity
to initiate, alter or change
the medication or therapeutic
according to protocol

Once a diagnosis has been established or a treatment
plan prepared for an individual patient, the responsibility
for clinical management may be transferred from
the assessing clinician (an independent prescriber)
to another health professional. Dependent prescriber
is not responsible for the initial assessment or diagnosis,
which rests with the assessing clinician

Makes initial diagnosis and decision
to treat. The act of prescribing for
a patient presenting for the first time
in an episode of care

Prescribe according to protocol
for emergent clinical condition

Therapy limited to formulary
or selection by protocol

Initial diagnostic decision has been made and treatment
initiated

Therapy is selected according
to defined scope of practice

Therapy selection by protocol

Limited pre-approved formulary

Prescribing according to patient specific management plan
or collaborative agreement

Prescribe/manage ongoing therapy
without pre-defined protocol

Continuing, discontinuing
and initiating therapy according
to pre‑approved protocol

Formulary limited to scope of practice or collaborative
agreement

Formulary based on scope
of practice

Increasing skill level, decision making and accountability

Example
Education
requirements

• Undergraduate degree

• Undergraduate degree

• Undergraduate degree

• Undergraduate degree

Example
Registration
requirements

• Regulated health
professional

• Regulated health professional

• Regulated health professional

• Regulated health professional

Example
competencies

• Signs & symptom
recognition in acute care

• Signs & symptom recognition

• Management of knowledge to patients condition
according to care plan

• Diagnostic skills relevant to scope
of practice and/or specialty area
of practice

• History taking

• Follow protocol

• Drug administration

• Credentialed

• History taking

• Follow protocols

• Drug administration

• Basic requirements for prescriptive
authority (following protocol)

• +/- Post graduate study

• Credentialed

• Full prescribing competencies in collaboration
with an independent prescriber

• Master’s or Doctoral degree

• Credentialed

• Diagnostic test ordering

• Full prescribing competencies

14
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2.2

What can nurses prescribe?
• durable medical equipment

What nurses can prescribe is different across
the world as it is based on diverse jurisdictional
authority and regulations. The scope of authority for prescribing is governed by different levels
of legislation within countries in addition to any
additional hospital/health agency prescribing
arrangements. Nurses can also only prescribe
within their areas of competence and according
to relevant guidelines. With this in mind, common areas of prescription include:

• appliances and certain dressings
• foods designated for specific therapeutic
purposes

• electrolytes3
When appropriate medicines for a patient condition are not included within a formulary or proto
col, the nurse prescriber may have the ability
to recommend over the counter medicines and
therapeutics as part of a management plan.

• medications
• therapies and therapeutics
2.3 Additional considerations
Collaborative Arrangements

collaborating nurse prescriber and supervisory
colleague (Hanson & Cahill 2019; Nuttall 2018).

Collaborative arrangements or collaborative
agreements are commonly used when there
are requirements for supervision of nurse prescribing. Collaborative agreements provide
a written description of the professional relationship between the nurse prescriber and a
collaborating independent prescriber (most
often a physician). The collaborating document
defines the parameters whereby the nurse can
perform delegated prescribing. At its core this
arrangement is aimed at placing the independent prescriber in a supervisory role relative to a
dependent prescriber (Hanson & Cahill 2019).

Some countries and jurisdictions are seeking
to remove collaborative agreements. The most
cited rationale for this was the time delays
and approval processes for the collaborative
practice agreement; confusing and burdensome governance arrangements when simpler
arrangements can be made; and the dissuading of nurses and midwives from developing
prescriptive authority as part of their practice
(Nursing & Midwifery Board of Ireland 2019).
Clinical management and monitoring
relevant to clinical status
(Nurse initiated diagnostic investigations)

A collaborative agreement could be as simple as a one-page written agreement defining
consultation and referral patterns to a more
specific protocol for identified functions based
on regulatory, legal and credentialing requirements in the country where the nurse has
prescriptive authority. Ideally, collaborative
agreements need to be written as broadly as
possible to allow for variations in nurse prescribing and changes in policy. As prescriptive
authority for nurses has evolved, in some settings specific protocols have been replaced by
evidence-based guidelines within a collaborative arrangement to allow for more flexible clinical practice. However, it should be noted, that
the specificity of a collaborative arrangement is
usually based on trust and respect between the

The introduction of nurse prescribing has often
included additional authorisations that support
best practice in prescribing.4 These permissions
include areas such as the ability to order diagnostic tests, diagnostic procedures, and other
investigations. These clinical decision-making
elements allow the nurse prescriber to further understand a person’s clinical needs and
explore possible diagnoses, thereby supporting
a comprehensive patient assessment.
Formularies

Many countries, health systems and hospitals
have developed committees to oversee the
development of formularies that set policies in

-3
4

In some countries, nurses are also able to prescribe blood and blood products.
These authorisations are becoming increasingly common in nursing and were first introduced for Advanced Practice Nurses.
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• Overprescribing – the prescription

relation to drugs and therapeutics. These committees have an impact on every prescriber,
dispenser and patient.

of medications for which no clear clinical
indication exists.

• Underprescribing – the omission

The original purpose of formularies was to
identify and designate drugs and therapeut
ics of choice to guide more rational prescribing. They can be used to assess, teach and
guide prescribing towards the most appropriate
choices for effective, safe and cost-effective
therapies. It can also mitigate the risks posed
by conflict of interest where the prescriber may
be influenced by industry (Noblet et al. 2017;
Schiff et al. 2012).

of potentially beneficial medications
that are clinically indicated for treatment
or prevention of a disease.

Inappropriate prescribing is a global phenomenon causing increased adverse drug events,
reduced quality of life, increased healthcare
costs and hospital readmissions (Gallagher
et al. 2011).5 This is one of the main drivers for
deprescribing.

Whilst there are many perceived benefits to formularies such as defining the limits of practice,
there are frequent negative examples of how
they have been used and implemented. These
concerns include a focus on cost containment;
creating needless hurdles and complexities for
prescribers and patients; and establishing barriers to nurse prescribing (Noblet et al. 2017;
Schiff et al. 2012).

Deprescribing has been defined as “the sys
tematic process of identifying and discontinu
ing drugs in instances in which existing or
potential harms outweigh existing or potential
benefits within the context of an individual
patient’s care goals, current level of function
ing, life expectancy, values and preferences”
(Scott et al. 2015). According to this description, deprescribing is a process of complex
decision making in which the risks and benefits
are weighed against the health needs of the
individual, patient preferences and quality of
life. The stopping and starting of medicines are
all part of the prescribing process.

For countries supporting and developing nurse
prescribing, it is important that formularies optimise the role of nurse prescriber instead of
creating artificial boundaries that impact on the
care they provide to individuals and communities. This can be achieved through ensuring
clear local policy and guidance on prescribing
based on the best evidence available. It is also
important that nurse leaders are involved on
the committees that establish formularies.

The main reasons for deprescribing include the
ceasing of medication because of an adverse
event, therapeutic failure and/or because the
future benefits of the medication no longer outweigh its potential for harm (Naughton & Hayes
2017). This is an important consideration for all
nurses, but in particular for those with prescriptive
authority as it will affect their prescribing practices.

Inappropriate prescribing
and deprescribing

According to O’Connor, Gallagher & O’Mahony
(2012), inappropriate prescribing covers the
following domains:

It is expected that nurse prescribers have a
demonstrated understanding beyond that of the
generalist nurse in the areas of pharmacology
and the ability to recognise the effects of medi
cines, allergies, drug sensitivities, side effects,
contraindications, incompatibilities, adverse
drug reactions, prescribing errors and polypharmacy (Wright et al. 2019). Each of the elements
in the preparation for prescriptive authority,
places the nurse in a good position to safely
deprescribe when it is appropriate and required.6

• Misprescribing – prescribing that involves

incorrect dose, frequency, modality
of administration or duration of treatment.
In addition, misprescribing includes
the use of medications that are likely
to cause clinically significant drug-drug
or drug‑disease interactions.

-5
Across several hospitals in Europe, a study concluded that between 35-77% of patients had been prescribed inappropriate medicines.
6

All nurses have an important role in medicine management and should have an influential voice amongst the healthcare team when it comes to
deprescribing. In addition to these responsibilities, it is recommended that nurse prescribers have a more active role in medication management.

16

CHAPTER TWO: MODELS OF NURSE PRESCRIBING

2.4

Immunization
does not have to be a prescriber but must complete immunization courses. In Nigeria, routine
immunization services in primary healthcare
are delivered by nurses, midwives and some
cadres of community health workers (Brown,
Oluwatosin & Ogundeji 2017).

The purpose of immunization programmes
and campaigns is to control vaccine preventable diseases among individuals and groups
identified as susceptible to disease. Nurses
worldwide play a critical role as healthcare
professionals within immunization campaigns,
however, their strategical role and the authority
with which they practice in this capacity varies
significantly globally. In the USA, provision of
immunization services is considered med
ical practice and under the sole control of a
physician even for advanced practice nurses
(Stewart, Lindley & Cox 2016). In Australia,
nurses are legally able to independently prescribe and administer vaccinations in most (but
not all) jurisdictions. In the United Kingdom
(UK), childhood immunizations fall within the
remit of the general practice nurse. In Ireland,
this falls under the remit of the general practice nurse, public health nurse, community
registered general nurse and registered general nurse. Travel health immunization clinics
in Ireland and the UK are mostly run by nurses
and more recently by pharmacists. When phys
icians prescribe vaccinations, these are generally limited to adult immunizations such as
pneumococcal and tetanus as the opportunity
arises during a consultation. In Spain, nurses
may independently prescribe vaccines on the
basis of the vaccination campaigns and the
vaccination schedule approved by the health
authorities.

One issue that arises in light of the variability of who provides immunizations is the limitation that extensive restrictions place on the
provision of immunizations by nurses. These
restrictions contribute to lack of access to
needed vaccines in a timely manner. One solution to this dilemma is the implementation of
standing orders programs (SOPs) for immun
ization practice to increase the uptake of vaccines (Stewart, Lindley & Cox 2016). SOPs
require a legal foundation authorising delegation of immunization services performed by a
wide range of healthcare providers (including
nurses), administered to broad patient populations in diverse settings. For clinical settings
with restrictions where providers are unable
to provide preventive vaccine services, the
implementation of SOPs positively influences
who can administer vaccines, permissible vaccines, eligible patients and the required level
of supervision. Thus, expanded authorisation
under SOPs could increase the ability to deliver
recommended services and remove barriers
that hinder an immunization programme. Under
this system, nurses can assess the need for a
vaccine, identify contraindications or precautions and administer vaccines without a direct
written physician or nurse practitioner order.
This can be an effective means to increase
immunization rates.

In Sub-Saharan Africa, physicians are not
usually involved in provision of immunizations. Immunization training is part of core pre-
registration nursing, be it at Diploma or BSc
level with assessed competencies. The nurse
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CHAPTER THREE

THE CASE FOR ACTION
Prescriptive authority for nurses and allied health professionals has been adopted across all
regions of the world. The most common reasons cited for this include:

• improved access and continuity to healthcare advice and services
• medical officer shortages, particularly in rural and remote areas
• improved efficiency of the healthcare system as nurses are able to provide complete episodes
of care, and reduce the number of encounters with multiple healthcare providers

• increased capacity of the healthcare system to meet demand and new ways of working
• enabling the healthcare workforce to work to their level of skill and education (i.e. increased
nurse autonomy and thereby increased job satisfaction for nurses)

• increased patient choice and health literacy with accessing medicines and services;
• greater capacity for patient centred care/continuity of care
• reduced risk to other health professionals who may be asked to prescribe for patients
they may not have seen

• improvement in patient care without compromising the quality of service provided
• improving the legal protection for nurse prescribing
(Crown 1999; Delamaire & Lafortune 2010; Maier 2019; NHS Wales 2017 ; Nissen, Lynne &
Bettenay 2015)

3.1

Universal Health Coverage

Access to acceptable, available and affordable
quality medicines is part of the United Nations
Sustainable Development Goals (SDGs 3.8)
(United Nations 2016). Poor access to quality
medicines and ‘fake’7 medicines around the
world often impedes progress on Universal
Health Coverage. It is recognised that this is
a multidimensional challenge and requires

3.2

numerous comprehensive policies and strategies. One pivotal strategy and positive en
abler of overcoming some of the issues is safe
prescriptive authority for nurses. This is an
evidenced based solution that has shown to
improve access to quality, safe and affordable
healthcare services (WHO 2019).

Medication safety

The WHO (2017) reports that unsafe medi
cation practices and medication errors are a
leading cause of “injury and avoidable harm
in healthcare across the world.” It is estimated that $42 billion USD is associated with

medication errors each year (Donaldson et al.
2017). This means that there is a real need to
improve the safety and quality of medication
practices to protect health providers, individ
uals and the community.

-7

Authentic versus imposter/falsified medications that have not undergone quality control measures.
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The framework outlines a holistic approach to
medication safety. This is an important concept
of nursing in general, and specifically when
implementing and supporting nurse prescribing. Seen in this context, safe prescribing is not
just the responsibility of the nurse prescriber,
it requires additional organisational approach
and coordination to ensure safety.

In response to these challenges, the WHO
developed the “Strategic Framework of
the Global Patient Safety Challenge” (see
Appendix 2). It depicts four domains to reduce
medication-related harm and includes:

• patients and the public
• healthcare professionals
• medicines and systems, and
• practices of medication
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CHAPTER FOUR

ORGANISATIONAL AND TEAM
SUPPORT FOR SAFE NURSE
PRESCRIBING
Safe prescribing is not just the responsibility of the individual. It requires a systems approach
including a supportive team and organisation. The following section focuses on the elements that
can contribute to quality, safe and effective nurse prescribing.

4.1

Decision support systems
• adherence to clinical guidelines, follow-up

Computerised clinical decision support systems can augment nurses in their practice.
Whilst there are many options with these types
of systems, the main functions include diagnostics, disease management, prescriptions, drug
controls, alerts, reminders, guidelines, patient
data sets, documentation and patient flow.

and treatment reminders

• maintain a variety of up-to-date

and evidence-based medicine-related
information

• reduced costs and improve efficiency
• improved documentation and other

The benefits of these systems include:

administrative functions

• reducing incidence of medication/prescribing

• improved communication between health

errors and adverse events

4.2

professionals thereby enhancing workflow
(Sutton et al. 2020)

Clinical governance, policies and procedures
Clinical governance policies and procedures
are important to be in place prior to the education of nurse prescribers. Standardised
approaches to policies ensure the quality of
care and patient safety, the lines of authority
and responsibility. A range of elements should
be covered by these including scope of practice, parameters, boundaries, support mechanisms, funding and continuing professional
development. These should be clearly documented and easily accessible to staff within the
organisation (Noblet et al. 2017).

Safe and effective use of medicines, including
prescribing, requires organisation-wide governance, leadership and commitment to support
the safe and effective use of medicines. Key
elements supporting nurse prescribing include:

• systems to monitor, review and improve

prescribing and medication management

• establishment of feedback processes

to nurse prescribers in order to support
changes to practice (if required), research
and/or participation in improvement activities

• establishing processes for nurse prescribers
to partner with consumers
(Flottorp et al. 2010)
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4.3

Peer support and relationships with interprofessional teams

Interprofessional relationships are an essential
component of quality and safe nurse prescribing. In particular, it is important that nurse prescribers have a collaborative relationship with
physicians, independent nurse prescribers and/
or pharmacists. In addition to clinical supervision, this assists in discussing difficult cases,
sharing knowledge, collaboration in practice,
helps avoid misunderstandings or disputes,
and builds professional confidence and trust
(Brodie, Donaldson & Watt 2014; GrahamClarke et al. 2018; Hindi et al. 2019; Stenner &
Courtenay 2008).

and implementation. In these circumstances,
physicians report the benefits of these models
as extremely helpful in improving access to care,
adherence to clinical treatment plans and con
tinuity of care (Noblet et al. 2018; Tatar 2015).
In some circumstances, patients with complex
healthcare needs see a range of healthcare
professionals including consultants, psychologists, pharmacists and other healthcare professionals. With such a broad team of healthcare
professionals, it is essential that a clear treatment plan is identified and shared. Important
linchpins within this multidisciplinary team are
pharmacists, who are a valuable source of
information on medications, drug interactions
and as a quality control measure to ensure
the accuracy of prescriptions (Graham-Clarke
et al. 2018).

A major barrier to nurse prescribing in many
parts of the world has resulted from the beliefs
and behaviours of physicians. Much of this
negativity has resulted from a lack of understanding of nurse prescribers’ roles and responsibilities with this resulting in physicians fearing
a loss of power and/or control. The evidence
suggests that physicians are often confused
about the amount of autonomy, responsibility
and accountability of nurse prescribers (Noblet
et al. 2017). This in turn has led to a lack of
support by the medical profession.

Peer support from other nurse prescribers is
critically important. Collaboratively working or
consulting with other nurses is a vital source for
gaining information, trouble shooting, encouragement and improving confidence. Evidence
has shown that when nurse prescribers work
together, nursing knowledge was expanded,
and prescribing decisions were made within
a faster timeframe (Jones & Cameron 2017);
Muzigaba et al. 2017; Stenner & Courtenay
2008).

Conversely, when physicians understand the
roles and responsibilities of nurse prescribers
and have been actively involved in the policy
development, there has been improved transition
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CHAPTER FIVE

A FRAMEWORK TO DEVELOP SAFE
AND COMPETENT PRESCRIBING
FOR THE NURSING PROFESSION
Prescribing is a complex process that requires the application of sound judgement, specific know
ledge, skills and attitudes to a unique person at a given point of time. This complexity is further
complicated by an increasing number of medicines available to the prescriber and the fact that
many people receive multiple medicines and a range of other treatments and therapies (including
traditional medicines) (NPS MedicineWise 2021).
The following framework is a guide to support safe and competent prescriptive authority for nurses.
The framework encompasses five core components. The requirements under each of the components may vary according to needs of the selected nurse prescribing model. It is recommended
that as part of the implementation of a framework such as this, that an education programme is
developed that can adequately assess to a set standard, the performance of the nurse seeking
prescriptive authority.

1. Completion of an accredited education programme
The health professional seeking prescriptive authority should complete an accredited
education programme that is consistent with
their scope of practice and demonstrates the
required level of competence. The education
should be accredited by the appropriate country

level nursing board or accreditation council.
Accreditation ensures that the course has the
appropriate content, and that the cur
ricu
la
meets or exceeds the standards that have been
developed by experts in the field in order to protect the nursing profession and the public.

Authorization
Authorization to prescribe

Regulation
Recognised the appropriate
regulatory authority of the
competence to prescribe
Education
Completion of an accredited
education program

03
02

04

01

Scope of Practice
Prescriptive authority
within scope of practice

05
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Continuing Professional
Development
Continuing prefessional
development to maintain
and enhance competence
to prescribe
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Core components
of the education programme

practising independently, advanced competencies are required in: history taking; physical
assessment; clinical test interpretation; diagnostic reasoning; clinical decision-making; and
comprehensive planning and monitoring for
patient needs encompassing all appropriate
pharmacologic and non-pharmacologic treatment options/considerations.

In order to achieve the knowledge, skills and
behaviours, it is recommended that education
curricula be designed to the appropriate level
of prescriptive authority and include the elem
ents within the following competency areas
described below. Competencies can be used as
the framework for an educational programme,
where they are broken into sub-competencies,
or knowledge/skills/attitudes and learning
objectives, with classroom and laboratory activities designed to build toward complete competency (ICN 2019). It should be noted that these
are minimum high-level requirements and have
not taken into consideration specific state, territory or country level needs.

Competencies

The education programme or course is dependent on country requirements in addition to the
prescribing model being considered. The education programme will require both theoretical
and practical elements that are overseen by an
authorised prescriber.

• places people at the centre of all practice
• promotes individual and community agency
• provides culturally sensitive, respectful,
and compassionate care

• incorporates a systems approach to health
• demonstrates clinical reasoning
and decision making skills.

Competency Area 2: Evidenced based
and informed practice

This competency focuses on the ability to identify and discuss appropriate, safe, effective and
evidence-based treatments. This includes the
ability to identify the most appropriate medicines; other non-pharmacological treatment
alternatives and the possibility that prescribing
may not be in the best interests of the patient.

Competency Area 1: People centredness
in care

As part of prescriptive authority, it is essential that nurses undertake a person-centred
approach to care. This means that the nurse
consciously adopts the perspectives of individuals, families and communities and sees
them as participants as well as beneficiaries of
healthcare. The nurse must be able to obtain
the necessary information and develop a plan
of care that is compatible with the needs of the
person who is ready, willing and able to take
action (WHO 2007). This competency includes
the knowledge, skills and behaviours required
to undertake a therapeutic partnership, perform
a comprehensive medicines assessment, and
generate and explore possible diagnoses.

Competencies

• identifies the most appropriate treatment
consistent with the individual’s needs

• avoids the overuse or misuse of resources
• maintains current knowledge of prescribing
protocols or algorithms according to the
healthcare system in which the healthcare
professional is practicing.

Competency Area 3: Communication
and Collaboration

Effective communication and collaboration are
key to any nurse prescriber’s practice. Nurse
prescribers at any level should have required
education preparing them to be competent in
communication and collaboration with both
patients and families, as well as with other
healthcare providers. Skills fostering clear
communication and therapeutic relationships
are essential for nurse prescribers for accurate
diagnosis and treatment of the patient, from
the initial stages of information gathering to

Formal education and preparation in the physio
pathology (and pharmacologic principles) for
the physiologic systems impacted by the prescribing by the nurse is crucial. Some degree
of diagnostic assessment and reasoning is also
key. While some form of competence would be
necessary at all levels, required preparation
for this competency is highly dependent on
the level of autonomy in prescribing as well as
level of clinical practice. For nurses who are
23
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planning pharmacologic and other treatments,
as well as in patient education. Nurse pre
scribers also must communicate clearly with
those dispensing, supplying or administering
medications, and be able to effectively collaborate in decision-making with other health professionals and family members involved in the
patient’s care. This competency area includes
the ability to appropriately document and safely
store and secure information.

Competencies

Competencies

• prepares prescriptions consistent with local

• has demonstrated knowledge of human
anatomy and physiology

• applies knowledge of pharmacological

actions in selected interventions
(i.e. this includes potential drug interactions)

• maintains up to date knowledge about

pharmacological agents according to scope
of practice
pharmaceutical laws and policies

• adapts communication to the goal(s),

urgency, and sensitivity of the interaction

Competency Area 5: Monitors and reviews
the person’s response to treatment

• listens actively and attentively

This competency focuses on the need to
monitor and review the person’s response to
treatment. This includes the ability to obtain
and interpret information in order to review
the effectiveness of the treatment plan and/
or alternative approaches to treatment. The
nurse prescriber needs to be able to effectively
communicate this with the patient and other
healthcare professionals. In addition, this area
focuses on the monitoring of unwanted effects
of the treatment plan, detecting and reporting
suspected adverse drug reactions and the ability to adapt a management plan according to
the patient’s needs and response to treatment.

• conveys information purposefully
• manages information sharing including

patient participation in decision making

• engages in collaborative practice
• builds and maintains trusting partnerships
Competency Area 4: Pharmacological
Essentials

Nurse prescribers should receive preparation
in pharmacologic essential principles appropriate to their level of prescribing and inclusive of
the populations and specialty areas for which
they will be prescribing. These pharmaco
logical essentials include competency in basic
pharmacologic principles including pharmacokinetics, pharmacodynamics, and pharmacotherapeutics to also include indications,
adverse effects, interactions, and contraindications for all classes of medications prescribed.
Competency in appropriate and rational drug
selection and prescribing, as well as monitoring
and re-evaluation would also be encompassed
in this essential education and preparation.
Also, preparation in documentation and
measurement enabling accurate, clear, complete conveyance of prescription information
in written or electronic form is a fundamental
pharmacologic competency. Finally, nurse
prescribers at all levels should be prepared to
maintain competence in these pharmacologic
essentials through the recognition and use of
appropriate pharmacologic resources for prescribing, and continued preparation in the form
of required continuing education.

Competencies

• continuously monitors the individual’s
response to pharmacological agents

• shares response information with colleagues
involved in care

• demonstrates a commitment to continual

quality improvement in treatment protocols

• enabling person-centred and evidence
informed practice

• reporting of suspected adverse reactions
(pharmacovigilance)

Competency Area 6: Practices professionally

It is incumbent on any nurse prescriber at any
level to practice with a fundamental understanding of their scope of practice. Nurse prescriber education and preparation, regardless
of the level of prescriptive authority, should provide competency in each of the aforementioned
areas. In addition to these proficiencies nurses
24
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These competency areas and their components
provide the cornerstones for the requisite education and preparation of nurse prescribers. It
should be noted that they are interrelated and
interdependent. Those developing the role of
the nurse prescriber should consider incorpor
ation, to some degree, of all of the areas with
further requirements delineated by the nurse
prescriber’s level of autonomy in prescribing
and the specific populations or specialty areas
in which the nurse is practicing and prescribing.
For the protection of both the nurse prescriber
and the patient, a minimum educational standard and educational requirements for prescribing
need to be set and met. In addition, educational programmes and mechanisms to provide
access to meet these needs should be offered.
These include not only formal preparation for
prescribing, but also for continuing education.

must demonstrate the elements of professionalism including the following competencies.
Competencies

• practising in accordance with relevant
legislation, regulations, and scope
of practice;

• adherence to policies and procedures
• takes responsibility for own decisions
and their consequences

• practices according to the code of conduct,
professional and ethical standards

• demonstrates a commitment to lifelong

learning and reflective practice
(Adapted from Nursing and Midwifery Council
2018).

2. Recognised by the appropriate regulatory authority
of the competence to prescribe
1. Regulatory authorities play an essential
role in the development, establishment,
implementation and regulation of nursing
roles. A core function of this body is to
protect the public by making sure that only
nurses who are appropriately educated,
qualified, competent and ethical in practice
are credentialed. In the case of nurse
prescribing, the regulatory authority has
two main functions: to set the standards
for competence to prescribe; and to
recognise the achievement of competence
by the health professional to prescribe
medicines consistent within their scope
of practice.
(Scanlon et al. 2020)

To support nurse prescribing, it is important
that the regulatory authority is able to identify
nurses who are authorised to prescribe. This
will ensure:

• employers can validate the competence
of the employee

• ongoing validation of the quality of care
provided

• research and development in prescriptive
authority for nurses

3. Authorised to prescribe
Authorisation to prescribe is permitted by the
relevant legislation, associated regulations
and professional standard within countries,
states, regions, or territories; and the policies
and procedures of health service providers in

which the nurse works. These instruments will
affect the medicines that nurses are authorised
to prescribe and therefore it is imperative that
nurses understand and practise according to
these.
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4. Prescriptive authority within scope of practice
Variations in scope of practice for nurse prescribing can be attributed to:

A nurse who is authorised to prescribe, does
so within their scope of practice. The scope of
nursing practice is defined within a legislative
and regulatory framework and describes the
competencies (knowledge, skills, attitudes and
judgement), professional accountabilities and
responsibilities of the nurse prescriber. It provides the foundation for establishing a standard for nursing practice, nursing education,
nursing roles and responsibilities. In addition,
it also conveys to the public the characteristics
of who is qualified to provide particular nursing
services. A clearly defined scope of practice
communicates to all stakeholders the competencies and accountabilities of the nurse (ICN
2013).

• an individual’s education, expertise
and experience

• the clinical setting where nurse prescribing
takes place

• the demand or need for nurses to prescribe
• nursing’s defined scope of practice

in the country, e.g. APN, generalised nurse,
specialised nurse

• legislative support or restriction
• required or specified competencies
• population of nursing practice: women,

children, elderly, palliative care, or disabled

Nurse prescribing has gradually become
included in the evolving definitions and descriptions of nursing’s scope of practice (Ladd &
Hoyt 2016; Schoer 2017). Prescriptive authority is most commonly associated with the
increasing emergence of Advanced Practice
Nursing (APN) and relevant scopes of practice
for the APN roles/advanced levels of nursing.
However, prescribing by nurses is not a new
phenomenon. The prescribing of pharmaceut
icals and therapeutics by nurses is a function
that is increasingly aligned to both advanced
and generalised nursing; however, the authority of nurses to prescribe is not standardised
globally.

• role development: level of prescribing may
be linked to the capability of the nurse to
do assessment and differential diagnosis

• associated with a country’s defined model(s)
of nurse prescribing

• flexibility and breadth of nursing scope

of practice – support or opposition varies
based on geographical location

• differences in structure and infrastructure
of healthcare systems

Scope of practice of the profession versus that of the individual, (Adapted from Pharmaceutical
Society of Australia 2016)

Professional scope

Legislation, Regulation, Standards (Ethics)

Individual scope
Skills
Knowledge
Attributes
Experience
Ethics
Accountability
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5. Continuing professional development to maintain
and enhance competence to prescribe
Continuing professional development (CPD)
is recognised as a means for maintaining
up-to-date knowledge and skills that influence prescribing competence to ensure quality healthcare and patient safety. In addition,
a study by Weglicki et al. (2015) found that
personal anxiety undermined confidence for
nurses to prescribe when prescriptive authority was included in their scope of prescriptive
thus access to CPD serves to support nurse
prescribers as they gain confidence while also
increasing clinical experience.

Continuing Professional Development can be
achieved in a number of ways. This includes:

• E-learning
• professional journals
• prescribing forums
• individual study, e.g. courses or modules
• work-based learning
• formal CPD study days
• action learning sets

Maintenance of professional competence
for nursing practice as well as for the nurse
prescriber is a continuous process. In some
countries, mandatory demonstration of CPD
is required for ongoing licensure and credentialing. The requirements and timeline for verification of competence maintenance is usually
determined by credentialing bodies or authorities. It is thought that this type of assessment
and reassessment ensures the credibility and
legitimacy of nurses, including nurse pre
scribers (Hanson & Cahill 2019; Hanson &
Hamric 2003; Schober 2019).

The means of obtaining CPD should be tailored
to the learning style and abilities of the individual nurse prescriber. In addition, accessibility
to learning options needs to align with their
competency-based requirements.
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CHAPTER SIX

MOTIVATION FOR NURSES TO SEEK
PRESCRIPTIVE AUTHORITY
The authority for nurse prescribing may be a country requirement or could depend on the motivation of a nurse to seek prescriptive authority. Study findings by Zimmerman et al. (Zimmerman
2020) found that perceived benefits by nursing to consider prescribing included:

• greater professional autonomy
• higher professional status
• higher remuneration
• greater work satisfaction
Concerns study participants identified included:

• greater legal responsibility
• reduced time for patient care
• no additional remuneration
• increased workload
• inadequate preparation
• conflicts in the therapeutic team
• lack of substantive organisational and collegial support
A country seeking to support nurse prescribing and the nurse prescriber should take benefits
and concerns into consideration when developing strategies and a framework guiding such an
initiative.

28

CHAPTER SEVEN: CRITICALELEMENTS SUPPORTING THE DEVELOPMENTAND ENHANCEMENT OF NURSE PRESCRIBING

CHAPTER SEVEN

CRITICAL ELEMENTS
SUPPORTING THE DEVELOPMENT
AND ENHANCEMENT OF NURSE
PRESCRIBING
7.1

Clinical guidelines: A professional standard

Nurse prescribing under the auspices of a professional standard ensures that the nurse practices lawfully, safely and effectively (Schober
2017). Suggested clinical guidelines include
the following:

Whilst these are recommended, it is recognised
that in some countries formal authorisation or
regulatory mechanisms might not be in place
despite the active practice of nurse prescribing.
In these circumstances, and looking toward
the future of nursing, ICN recommendations
can be viewed as aspirational and thus able
to be aligned with implementation strategies
that meet a professional standard and scope
of practice for nurse prescribing.

• licensed/authorised/registration

as a prescriber by a governmental authority

• nongovernmental authorities, such as

nursing professional bodies to provide
professional standards and guidance

Clinical practice guidelines are determined by
the country and the context in which the nurse
practices. Defined requirements include the
ability to:

• defined scope of nurse prescribing
• accountable for all prescribing decisions

made within an agreed level of experience
and competence

• perform a physical examination and history

• assessment – able to conduct

• assess the health status of a patient using

a comprehensive health assessment
including medication history

clinical judgement

• communication to other healthcare

• assess the therapeutic indication

• accurate record keeping

• assess potential contraindications/risk

for treatment: medicines, therapeutics

professionals and consent of the patient

for adverse medication interaction

• evidence-based/evidence-informed

• provide health education to the patient

prescribing

monitoring patient for side-effects
and response to management plans

• continuing professional development

to remain up to date with knowledge needed
to prescribe and maintain competence

• monitor and review of patient outcomes
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CHAPTER EIGHT

CONCLUSION
Debate about nurse prescribing has focused on the appropriateness of prescriptive authority
for nurses. Frequently this discussion is linked to the more general debate on advanced practice nursing (APN), however, literature confirms that nurse prescribing has been incremental, is
increasing and exists independent of APN roles. Nurse prescribing is one aspect of the advances
in nursing practice. The key question pointed out by Ball (ICN 2009) is not “Can nurses prescribe”
in a country, but “To what extent is nurse prescribing established?” The level, extent, scope and
prevalence of nurse prescribing vary from country to country and even within countries.
This guidance paper offers key elements to consider in the process of achieving and supporting
nurse prescribing. The following should be considered:

• Is there a need for healthcare services that include nurse prescribing?
• What regulations and legislation are needed to support this practice?
• Are there identifiable professional organisations that support nurse prescribing?
• Is there a framework or model for nurses who have prescriptive authority?

ICN POSITION ON PRESCRIPTIVE
AUTHORITY FOR NURSES
Prescriptive authority for nurses can play an important part in improving healthcare outcomes by
enhancing effective and efficient healthcare service provision. Nurses with prescriptive authority
can facilitate the provision of more integrated patient care thus enhancing the overall quality of
healthcare services. In addition, nurses with prescriptive authority gain an increased sense of
professional satisfaction.
Prescribing is a complex process. Realisation of the aforementioned improvements requires, as
appropriate and applicable, a supportive regulatory and policy environment, governance structures, organisational culture, appropriate education and professional development. The ‘ICN
guidelines on prescriptive authority for nurses’ intend to support the implementation and ongoing
development of nurse prescribing to protect the patient as well as the healthcare professional and
safeguard the healthcare system.
Nurse prescribing is sensitive to the country context and the healthcare culture in which it de
velops. Therefore, the approach to defining and implementing nurse prescribing follows a distinctive pattern in different countries.
There are multiple models for nurse prescribing. These models are generally differentiated by
the levels of nurse competencies as well as the depth of decision making and accountability.
Prescriptive authority should be seen as a continuum. As independence and accountability of
prescriptive authority for the nurse increases, so too will the requirements for higher levels of education, continuing professional development and regulatory mechanisms to verify that a baseline
level of competencies has been achieved.
ICN, therefore, calls on governments to ensure the appropriate levels of education and regulation of
the profession are in place to lay the groundwork for expanding nurse prescribing throughout the world.
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APPENDICES
Appendix 1: Differentiating between dependent/supplementary
and independent prescribing
(Adapted from Stewart et al. 2017)
AREA

SUPPLEMENTARY/DEPENDENT
PRESCRIBING

INDEPENDENT PRESCRIBING

Clinical conditions
managed

Any, within their clinical competence

Any, within their clinical competence

Diagnosis
responsibilities

An independent prescriber must
diagnose the condition before
enabling an authorised supplementary
prescriber to commence

The independent prescriber can
assess and manage patients with
diagnosed or undiagnosed conditions

Need for a clinical
management plan

A written or electronic patient specific
‘clinical management plan’ or protocol
must be in place before supplementary
prescribing can commence

No prearranged care plan required.
The independent prescriber develops
a management plan

Need for formal
agreement

The ‘clinical management plan’ must
be agreed with the independent
prescriber and patient before
supplementary prescribing
can commence

No need for any formal agreement

Often called a collaborative agreement
Drugs prescribed

Any, within their scope of practice
and under supervisory agreement
and consultation
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Appendix 2: Nurse prescribing: The global regulatory landscape – 2020
The growth of regulatory oversight of nurse prescribing around the world has evolved rapidly over
the past several decades. During the 1980s and the 1990s, prescribing by nurses accelerated with
the expansion of nurse practitioner scope of practice in the USA and the need to codify clinical
practices that support the prescribing of medicines. In the UK, nurse prescribing by post-basic
nurses was authorised with the Medicinal Products: Prescription by Nurses Act of 1992 (Royal
College of Nursing 2014). The turn of the 21st Century brought further expansion of nurse prescribing in Canada, Europe, Australia and New Zealand, officially sanctioned by both regional
(provincial or state) and national governments. This trend also expanded in Africa with the roll
out of low cost, anti-retroviral therapy for the treatment of HIV/AIDs (Zuber et al. 2014). In Spain,
nurse prescribing was incorporated into law by an Act of 2009.
Generally, the regulatory expansion of prescriptive authority for nurses has been predicated on
the necessity to mitigate demands that are associated with health worker shortages, and in other
cases it is simply based on a move toward the improvement of financial and organisational efficiencies of the healthcare delivery system.
The literature on the regulatory provisions of nurse prescribing has grown in recent years, however, it has largely focused on high-income countries. The purpose of this appendix is to provide a
broader index of current global data on statutory and regulatory provisions that have been established to authorise nurse prescribing, based on the WHO designated world regions.
1) The Americas
a. North America
The USA has a long history of statutory authority for nurse prescribing, predominantly
for nurse practitioners. Currently, all 50 states and the District of Columbia permit some
level of independent prescribing by advanced practice nurses (nurse practitioners, clinical
nurse specialists and nurse midwives), albeit with state-to-state variability in relation
to scope of practice and physician oversight (American Nurses Association n.d.).
Canada also has broad prescriptive authority for nurse practitioners which is authorised
at the federal level (Canadian Nurses Association 2015; College of Nurses of Ontario;
Government of Canada 2012). In addition, two provinces in Canada, Alberta and Ontario,
have passed laws that permit nurse prescribing at the post-basic level (registered nurse)
(College & Association of Registered Nurses of Alberta 2019). The Canadian provisions
for nurse practitioners were established as federal regulations based on existent statutes.
Post basic prescribing in Alberta and Ontario were written as provincial level statutes
and are currently in the process of being implemented.
b. Latin America/Caribbean
In Latin America, nurses who have the authority to prescribe medications essentially
function at the post-basic level. Brazil, Columbia and Mexico allow nurses to prescribe,
mostly in the primary care and public health setting (Hernandez et al. 2015; Martiniano
et al. 2015; Secretaría de Gobernación 2017). Nurse prescribers in the Caribbean work
at the advanced practice level, primarily as Family Nurse Practitioners and most have
the authority to prescribe most medications that are used in primary care (Ministry of
Health 2012b). In Belize, only psychiatric nurse practitioners are able to prescribe, and
that authority is limited to psychotropic drugs. However, nurse practitioners in Jamaica,
the location of the largest nurse practitioner educational programme in the Caribbean
(University of the West Indies), are still not legally able to prescribe medications.
2) Africa
Ten countries in Africa have been identified as having some type of regulatory or statutory
authority for nurse prescribing, the majority of which permit prescribing at the post-basic level.
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A phenomenon that has developed over the past two decades, Nurse Initiated and Managed
Anti-Retroviral Therapy (NIMART) has been broadly adopted in countries with a high burden
of disease of HIV and AIDS. This approach has supported post-basic nurses to manage
HIV patients, especially in areas of health worker shortages (Zuber et al. 2014). Generally,
most nurses that can legally prescribe drugs in Africa can do so at the post-basic level. Only
two countries – Botswana and South Africa - recognise advanced practice nurses as legal
prescribers (Dumas & Cariou 2014; Monyatsi et al. 2011; South African Nursing Council 2012a).
3) Europe
Prescribing by nurses developed approximately 30 years ago in the UK and has subsequently
been legally established in 14 additional countries on the continent and Israel. The majority
of this prescribing occurs by nurses at the post-basic level. More and more countries have
granted or are developing the APN role with prescriptive authority (Maier, 2019). Generally,
the extent and scope of prescribing is limited to varying degrees in most countries. Only three
countries/regions in Western Europe have granted almost full prescriptive authority based on
clinic focus: Ireland, the Netherlands and the UK (Maier 2019). In Spain, prescriptive authority
for nurses has been incorporated into the undergraduate university education curriculum since
2008. Regulations to enact this process were finalised in 2009. Once employed as a nurse,
students who have achieved the competencies and graduate from an undergraduate nursing
programme are capable of prescribing.
The battle for the rights of nurses in Iceland to prescribe hormonal contraception has extended
over more than two decades. In December 2018, the pharmaceutical laws and laws about
the Directorate of Health were changed by the Icelandic parliament to include nurses and
midwives as healthcare professionals to be allowed to prescribe hormonal contraception.
In January 2021, the regulation regarding the prescription rights of nurses and midwives in
Iceland took effect. The School of Nursing at the University of Iceland started to offer courses
in January 2020, for master level students in primary health care nursing, graduated nurses,
midwifery students and graduated midwives.
4) Southeast Asia
Thailand has had some level of prescribing by nurses over the past two decades. In 2002,
the Thai government promoted nurse practitioners as strategic professionals, especially in
community clinics. Their authority to prescribe medicines via a formulary has helped to expand
their scope of practice (Hanucharumkul 2007; WHO 2016). The Indian Nursing Council has
recently established a nurse practitioner in critical care role which allows prescribing in acute
care settings via protocol (Indian Nursing Council 2016). India has also recently authorised
a Mid-level Health Provider which is embedded in the community nursing role. This position
also includes the authority to prescribe treatments via protocol (Indian Nursing Council 2018).
5) Western Pacific
There has been substantive and rapid movement on nurse prescribing in the Western Pacific
region. Both Australia and New Zealand have established regulations that permit prescribing
by post-basic nurses as well as nurse practitioners. Australia requires a structured prescribing
agreement in the form of standing orders or protocols. Independent prescribing started in 2000
within the context of the nurse practitioner role (Australian Nursing & Midwifery Federation
2018). New Zealand initially permitted post-basic nurses to prescribe in the diabetes clinical
area, however, this was expanded to include a broad scope of medicines, based on regulations
that were promulgated in 2016 (Midcentral Health Nursing Department n.d.; Nursing Council
of New Zealand n.d.).
Other high-income countries in the region, such as Singapore and South Korea allow nurse
prescribing at the APN level only (Liew 2018; Oita University of Nursing & Health Services
2016; Schober & Green 2018). Vietnam, an emerging economy, also permits nurse prescribing
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for the recently developed nurse practitioner role (The Voice of Vietnam Online 2016). Tonga
and Papua New Guinea, both low-income countries with limited resources, permit nurses at
the post basic level to prescribe medicines (Gregorio 2017; Matangi Tonga Online 2014).
***
Nurses are increasingly attaining the authority to prescribe medications, granted either by national
or regional statute, or other governmental bodies (e.g. Ministry of Health). This expanding scope
of practice reflects the ongoing evolution of nursing practice, primarily in response to national level
needs based on improving efficiencies or to mitigate physician shortages.
This review has identified 44 countries in five WHO Regions that have formal laws or regulations
that permit prescribing by nurses (Figure 1). Of these 44 countries, 70% (31 countries) formally
permit nurse prescribing at the post-basic level. This is defined as prescribing by nurses who
have completed their basic nursing education, either at the diploma or bachelor’s degree level.
Thirty percent (13 countries) permit prescribing by nurses at the advanced practice level exclusively. Twenty-five percent of the total authorise nurse prescribing at both the post-basic and
advanced practice level (Figure 1).
The predominant model of nurse prescribing worldwide is prescribing that occurs at the post-basic
level. When considering the potential cause of this trend, it is important to note the economic
category of each country. Based on the World Bank economic classification (World Bank 2019),
data indicates that 38% of low- to middle-income countries authorise prescribing at the post-basic
level vs. 31% at the high-income level (Figure 2). This indicates that the difference between two
country-based income levels is not large and suggests that the focus of nurse prescribing, even
in disparate settings is the same, that is, to inject core efficiencies into systems that struggle with
central healthcare system constraints. There is a greater difference between nurse prescribing
authorised at the advanced practice level between low- to middle-income and high-income countries. High-income countries authorise nurse prescribing at the advanced practice level at higher
rates than low-income countries (34% to 18% respectively) (Figure 2). This could be a result of
educational and health system infrastructure (including high quality regulatory frameworks) in
low-income countries that are not able to extensively support nursing education at the advanced
practice or master’s degree level.
The findings of this review significantly expand on existing literature by highlighting that statutory
authority for nurse prescribing is not only expanding in high-income countries, but is concomitantly
expanding in low- to middle-income countries as well. In particular, the expansion of nurse prescribing in Africa is noteworthy. Ten African nations have formal regulations that permit nurse prescribing. Six of these authorise focused prescribing by post basic nurses: five permit prescribing
of antiretroviral medications and one permits prescribing for palliative care. Prescribing by nurses
in the HIV/AIDS context is termed Nurse Initiated and Managed Antiretroviral Therapy (NIMART),
an innovative global initiative that has been widely acknowledged to increase access to HIV treatment and to improve health services equity in Sub-Saharan Africa (Holmes et al. 2021; Zuber
et al. 2014). NIMART, which represents the process of “task sharing” or “task shifting” of care from
physicians to adequately educated nurses in environments with health workforce shortages, has
been found to have clinical results that are comparable to physician care in terms of quality of care
and better outcomes related to client retention and lower loss to follow up (Iwu & Holzemer 2014;
Kredo et al. 2014). Also importantly, other low- to middle-income nations, such as Thailand, India,
Tonga and Papua New Guinea have adopted regulations that permit nurse prescribing, likely to
address the similar workforce shortages, especially in community and rural settings (WHO 2016).
In contrast to the exigencies of healthcare in low- to middle-income nations, high-income nations
have also rapidly expanded their regulations around nurse prescribing. In the European region,
nurse prescribing and associated regulations have expanded significantly over the past decade
(Maier 2019). Whilst there are many reasons for the implementation of nurse prescribing, one
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of the biggest drivers appears to be that countries are looking to innovative healthcare delivery
models as they struggle with the burden of increasing chronic disease and an aging population.
Conclusion

While regulatory approval varies significantly by region and country, it is clear that prescribing by
nurses is a growing phenomenon. And, importantly, as evidenced by this review, it is not limited
to high-income nations. Governmental authority for prescribing by nurses has grown significantly
in low- to middle-income countries, with models that rely largely on generalist nursing. Based on
all identified countries in this analysis, the predominant model is that of prescribing by post-basic
nurses. Future research should investigate the education and competency-based qualifications
of nurse prescribers and the impact the prescribing has on nursing practice. In addition, these
delivery models warrant further inquiry into patient outcomes around quality and satisfaction as
well as value for money.
FIGURE 1: NURSE PRESCRIBING BY STATUTE/REGULATION/ECONOMIC CATEGORY
Statute/
Regulation

Broad

Focused

Level

World Bank
Category

THE AMERICAS: NORTH AMERICA
USA (NCSL Scope of
Practice Policy 2019)

X

X

APN

H

Canada (Canadian
Nurses Association
2015; Government
of Canada 2012)

X

X

Post-basic,
APN

H

APN

LMI

Post basic
NP

LMI

THE AMERICAS: SOUTH AMERICA/CARIBBEAN
Montserrat (Ministry
of Health Montserrat
2012)

X

X

Belize (PAHO, WHO,
Belize Ministry
of Health 2009)

X

Brazil (Martiniano
et al. 2015)

X

X

Post basic

LMI

Columbia (Zamora,
Londono &
Palacios 2010)

X

X

Post basic

LMI

Mexico (Secretaria de
Gobernación 2017)

X*

X

Post basic

LMI

St. Lucia (St. Lucia
Ministry of Health
2012)

X

X

APN

LMI

Dominica
(Commonwealth
of Dominica 2014)

X

X

APN

LMI

X
(Psychotropics
only)
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FIGURE 1: NURSE PRESCRIBING BY STATUTE/REGULATION/ECONOMIC CATEGORY
Statute/
Regulation

Broad

Ghana (Ministry of
Health Ghana 2004)

X

Kenya (Nursing
Council of Kenya
2019)

Focused

Level

World Bank
Category

X

Post basic,
APN

LMI

X

X

Post basic

LMI

South Africa
(South African
Nursing Council
2012b)

X

X

Post basic,
APN

LMI

Botswana (Duma
et al. 2014)

X

X

Post basic,
APN

LMI

Zambia (Zuber
et al. 2014)

X

X (HIV)

Post basic

LMI

Namibia (Zuber
et al. 2014)

X

X (HIV)

Post basic

LMI

Zimbabwe (Zuber
et al. 2014)

X

X (HIV)

Post basic

LMI

Eswatini (Zuber
et al. 2014)

X

X (HIV)

Post basic

LMI

Tanzania (Tanzania
Nursing & Midwifery
Council 2014)

X

X

X (HIV)

Post basic

LMI

Cameroon
(Ngoasong
& Groves 2015)

X

X

Post basic

LMI

Uganda (Downing
et al. 2017)

X

Post basic

LMI

AFRICA

X
(Palliative
Care)

EUROPE
Estonia (Habicht
2017: Maier 2019)

X

X

Post basic

H

Finland (Maier 2019;
Merasto 2014)

X

X

Post basic,
APN

H

Iceland

X

Post
graduate

H

X
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FIGURE 1: NURSE PRESCRIBING BY STATUTE/REGULATION/ECONOMIC CATEGORY
Statute/
Regulation

Broad

Ireland (Nursing &
Midwifery Board of
Ireland 2017; Office
on Nursing Services
Director: Ireland
2008)

X

Netherlands (Maier
2019); Kroezen
et al. 2011a)

X

Norway (Skjeldestad
2012)

X

Poland (Zarzeka
et al. 2017)

X

Sweden (Maier 2019)

Focused

Level

World Bank
Category

X

Post basic,
APN

H

X

Post basic,
APN

H

Post basic

H

X

Post basic
(refills),
specialist
(Masters)

H

X

X

Post basic

H

United Kingdom
(Maier 2019)

X

X

Post basic,
APN

H

France (Maier 2019)

X**

Post basic

H

Cyprus (Maier 2019)

X**

APN

H

Spain (Maier 2019)

X

Post basic

H

Denmark (Maier
2019)

X

Post basic

H

APN ****

H

APN

H

EUROPE

X
(Contraception)

X

X
(Refill only)

Switzerland
(Maier 2019)
Israel (Schober
& Green 2018)

X***

X
(Palliative care,
geriatrics, DM,
NICU, surgical
ICU)

SOUTHEAST ASIA
Thailand
(Hanucharurnkui
2007; WHO 2016)

X

X

APN

LMI

India (Indian Nursing
Council 2016 & 2018)

X

X

Post basic,
APN

LMI
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FIGURE 1: NURSE PRESCRIBING BY STATUTE/REGULATION/ECONOMIC CATEGORY
Statute/
Regulation

Broad

Singapore
(Liew 2018)

X

South Korea
(Schober & Green
2018)

Focused

Level

World Bank
Category

X

APN

H

X

X

APN

H

Taiwan (ibid)

X

X

APN

H

Vietnam (The Voice
of Vietnam Online
2016)

X

X

APN

LMI

Australia (Australian
Nursing and
Midwifery Federation
2018)

X

X

Post basic,
APN

H

New Zealand
(Nursing Council of
New Zealand n.d.)

X

X

Post basic,
APN

H

Tonga (Matangi
Tonga Online 2014)

X

X

Post basic

LMI

Papua New Guinea
(Gregorio 2017;
Joshua et al. 2014;

X

Post basic

LMI

WESTERN PACIFIC

* legislation enacted, unclear if current practice
** legislation enacted, waiting implementation
*** refill only
**** nurse specialist with Master’s degree
***** adjust medications, perform IV rehydration, limited to Canton Vaud
		H – High-income country per World Bank
		LMI – Low- to middle-income country per World Bank
Broad – For the purposes of this paper, broad refers to comprehensive and wide range of pharmaceuticals
and therapeutics.
Focused - For the purposes of this paper, focused refers to the limitations of prescribing to a specific clinical
condition (e.g. HIV) or pharmaceuticals.

Figure 2: Nurse Prescriber Level by Country Economic Level
LOW- TO MIDDLE-INCOME

HIGH-INCOME

Post Basic Nurse

38%

31%

Advanced Practice Nurse

18%

34%
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Appendix 3: WHO Strategic Framework of the Global Patient
Safety Challenge
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